Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives Average Rating of “Moderate Buy” from Analysts
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-one research firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating, fifteen have assigned a buy rating and one has assigned […]
More Stories
SAB Biotherapeutics, Inc. (NASDAQ:SABS) Sees Large Decrease in Short Interest
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) was the target of a significant decrease in short interest in the...
Valmet Oyj (OTCMKTS:VOYJF) Sees Large Decrease in Short Interest
Valmet Oyj (OTCMKTS:VOYJF – Get Free Report) was the recipient of a significant drop in short interest during the month...
Ubisoft Entertainment SA (OTCMKTS:UBSFY) Sees Significant Decrease in Short Interest
Ubisoft Entertainment SA (OTCMKTS:UBSFY – Get Free Report) was the target of a large drop in short interest in the...
SecureWorks Corp. (NASDAQ:SCWX) Short Interest Down 33.4% in October
SecureWorks Corp. (NASDAQ:SCWX – Get Free Report) was the target of a significant drop in short interest in October. As...
SecureWorks Corp. (NASDAQ:SCWX) Short Interest Down 33.4% in October
SecureWorks Corp. (NASDAQ:SCWX – Get Free Report) was the target of a significant drop in short interest in October. As...
SLM Co. (NASDAQ:SLMBP) Short Interest Update
SLM Co. (NASDAQ:SLMBP – Get Free Report) was the recipient of a large drop in short interest in October. As...